In the study, researchers analyzed data from a large, nationally representative U.S. claims database with more than 330 million covered lives with commercial insurance, Medicare and Medicaid, and included inpatient, outpatient and pharmacy claims. The study found annual healthcare costs per patient are significantly higher than previously described, higher than other expensive-to-treat rare diseases and exceedingly higher in people who are anemic and require hematological support.